Listen Up

Thursday, August 29, 2024

Tampons, hidden danger


Tampons can sometimes contain trace amounts of heavy metals, primarily from the manufacturing process, but these levels are generally very low and within safety regulations. Some studies have suggested that certain brands may contain detectable levels of metals like lead or cadmium, often due to environmental contamination or the materials used.


If you're concerned about heavy metals in tampons, consider looking for brands that emphasize organic materials or have been tested for contaminants. Always check product labels and consult independent studies or consumer reports for more detailed information on specific brands.

A new study that detected variable levels of heavy metals, including lead, in tampons currently on the market is being reviewed by the U.S. Food and Drug Administration, a spokesperson for the agency told ABC News.


The study published in Environmental International by researchers at the University of California, Berkeley, evaluated the levels of 16 types of metals, including lead as well as mercury, arsenic and iron, in 30 tampons from 14 different brands obtained in the U.S., Greece and England.


Differing levels of metals were found on materials of all 30 tampons, which included both organic and non-organic brands, according to the study, published July 3.


The study's authors noted that it is not clear whether the metal levels found in the tampons would contribute any negative health effects to users but called for more research to be done.

"Despite this large potential for public health concern, very little research has been done to measure chemicals in tampons," the study's lead author, Jenni A. Shearston, a postdoctoral scholar at the UC Berkeley School of Public Health and UC Berkeley's Department of Environmental Science, Policy, & Management, said in a statement. "To our knowledge, this is the first paper to measure metals in tampons."

Shearston added, "I really hope that manufacturers are required to test their products for metals, especially for toxic metals. It would be exciting to see the public call for this, or to ask for better labeling on tampons and other menstrual products."

Kotex recalls some tampons after reports of 'unraveling' and 'pieces left in the body.

Kimberly-Clark issued a voluntary recall yesterday for some of their U by Kotex tampons, amid reports from consumers of them "unraveling and/or coming apart upon removal," according to a statement on their website.


 

Wednesday, August 28, 2024

On the COVID ‘Off-Ramp’: No Tests, Isolation or Masks

What should we do?

In the fifth summer of COVID, cases are surging, and the Centers for Disease Control and Prevention has reported “high” or “very high” levels of the virus in wastewater in almost every state. The rate of hospitalizations with COVID is nearly twice what it was at this time last summer, and deaths — despite being down almost 75% from what they were at the worst of the pandemic — are still double what they were this spring.




As our spike protein friend is mutating another round of Covid aproaches. Although it is highly infectious, it is nowhere near as virulent. 

As children return to schools and Labor Day weekend travel swells, the potential for further spread abounds. But for many like Moyer, COVID has become so normalized that they no longer see it as a reason to disrupt social, work or travel routines. Test kit sales have plummeted. Isolation after an exposure is increasingly rare. Masks — once a ubiquitous symbol of a COVID surge — are sparse, even in crowded airports, train stations and subways.

Human behavior is, of course, the reason that infections are soaring. But at some point, many reason, we need to live.

I no longer even know what the rules and recommendations are,” said Andrew Hoffman, 68, of Mission Viejo, California, who came down with respiratory symptoms a few weeks ago after his wife had tested positive for COVID. He skipped synagogue, but still went to the grocery store.

“And since I don’t test, I can’t follow them,” he said.

Epidemiologists said in interviews that they do not endorse a lackadaisical approach, particularly for those spending time around older people and those who are immunocompromised. They still recommend staying home for a couple of days after an exposure and getting the newly authorized boosters soon to become available (despite the poor turnout during last year’s round).

But they said that some elements of this newfound laissez faire attitude were warranted. While COVID cases are high, fewer hospitalizations and deaths during the surges are signs of increasing immunity — evidence that a combination of mild infections and vaccine boosters are ushering in a new era: not a post-COVID world, but a postcrisis one.

Epidemiologists have long predicted that COVID would eventually become an endemic disease, rather than a pandemic. “If you ask six epidemiologists what ‘endemic’ means, exactly, you’ll probably get about 12 answers,” said Bill Hanage, associate director of the Center for Communicable Disease Dynamics at Harvard T.H. Chan School of Public Health. “But it certainly has a sort of social definition — a virus that’s around us all the time — and if you want to take that one, then we’re definitely there.”

Certain threats remain clear. For vulnerable groups, the coronavirus will always present a heightened risk of serious infection and even death. Long COVID, a multifaceted syndrome, has afflicted at least 400 million people worldwide, researchers recently estimated, and most of those who have suffered from it have said they still have not recovered.

But the CDC director, Dr. Mandy Cohen, called the disease endemic last week, and the agency decided this year to retire its five-day COVID isolation guidelines and instead include COVID in its guidance for other respiratory infections, instructing people with symptoms of COVID, RSV or the flu to stay home for 24 hours after their fever lifts. The updated guidelines were an indicator that, for most people, the landscape had changed.

If the Olympics were any barometer, the rest of the world seems to have exhaled as well. In Tokyo in 2021, there were daily saliva samples, plexiglass dividers between cafeteria seats and absolutely no live spectators; the arenas were so empty that coaches’ voices echoed. In Beijing in 2022, under China’s zero-tolerance policy, conditions were much the same.

But in Paris last month, the organizing committee for the 2024 Olympics offered no testing requirements or processes for reporting infections, and so few countries issued rules to their athletes that the ones that did made news.


As they said in '
Wayne's World". Parte on !


On the COVID ‘Off-Ramp’: No Tests, Isolation or Masks

Health Insurance Barriers Delay, Disrupt and Deny Patient Care | US News Opinion




This is a long and detailed post about a battle that 62% of patients deal with on a daily basis.

The information was published by ProPublica, an independent internet publication, which is highly respected and supported by donations.





At times legal action is your recours.  Remember to keep meticulous records.
Insurance companies record all conversations which may work against them.
Finally insurers often LIE.

Tuesday, August 27, 2024

Is your Medical Record safe from LLMs and ChatGPT

The answer is Yes.

Can LLMs or AI (ChatGPT) access the Electronic Medical Record?

Large language models (LLMs) ensure patient privacy in several ways:

No Direct Access: LLMs do not have access to electronic health records or personal data. They operate based on pre-existing knowledge and patterns learned during training.


Data Anonymization: Training data is typically anonymized, meaning personal identifiers are removed. This reduces the risk of generating responses that could inadvertently reveal private information.
Strict Compliance

Developers of LLMs adhere to privacy regulations, such as HIPAA, which govern the handling of sensitive health information.
Controlled Environments: 

When LLMs are used in healthcare settings, they are often implemented in controlled environments with strict access controls and monitoring.
User Prompts: LLMs are designed to avoid engaging with prompts that request sensitive personal information or that might compromise privacy.
Ethical Guidelines: Organizations deploying LLMs often follow ethical guidelines that prioritize user privacy and data protection.

In addition to the limitations for LLMs

The electronic health record (EHR) system is designed to protect patient information in several ways:

Access Controls:

EHRs have robust user authentication and authorization mechanisms, such as secure login credentials, multi-factor authentication, and role-based access controls.

Healthcare providers and staff can only access the specific patient information they need to perform their job duties.

Data Encryption:

Patient data stored in the EHR is encrypted using advanced encryption algorithms to protect it from unauthorized access.

Data transmitted between the EHR and other healthcare systems or patient portals is also encrypted to ensure confidentiality.

Audit Trails:

EHRs maintain detailed audit logs that record all access, modifications, and actions performed on patient data.

These audit trails help healthcare organizations monitor and investigate any suspicious or unauthorized activities.

Data Backups and Disaster Recovery:

EHR systems implement regular data backups and have robust disaster recovery plans to ensure the availability and integrity of patient information in case of system failures or natural disasters.

Compliance with Regulations:

EHR systems are designed to comply with various healthcare privacy and security regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States.

These regulations set strict standards for the protection of patient information and impose penalties for non-compliance.

Physical Security:

EHR systems are hosted in secure data centers with physical access controls, such as biometric scanners and security cameras, to prevent unauthorized physical access to the systems.

Patient Engagement and Control:

Many EHR systems offer patient portals, allowing patients to access and review their own medical records, as well as request corrections or express concerns about the privacy of their information.

By implementing these security measures, EHR systems aim to protect the confidentiality, integrity, and availability of patient information, ensuring that healthcare providers can securely access and manage patient data while maintaining the trust and privacy of patients.

Tuesday, August 20, 2024

Health News Notes

US Birth Rate Hits New Low




Mpox outbreak concerns grow


More Than Half of IRA Negotiation Savings to Come From Three Drugs:


Continuing our discussion about Medicare Drug Price Negotiations.

Amgen’s Enbrel, Bristol Myers Squibb’s Eliquis and Johnson & Johnson’s Stelara will account for 51.4% of the Inflation Reduction Act’s drug price negotiation savings in 2026, according to the Brookings Institution.


A little known feature of the IRA gave CMS the ability to negotiate drug prices.

These savings indicate how much of the federal government's budget goes to Medicare's drug benefit for seniors.

The drugs were designed to treat some of the most frequent illnesses in the population, arthritis, blood clots in heart disease, and psoriasis.




More Than Half of IRA Negotiation Savings to Come From Three Drugs: Report - BioSpace

Monday, August 19, 2024

Medicare has negotiated price cuts for 10 Drugs


CMS (Medicare) controls a large part of the pharmaceuticals used by patients and they have considerable influence on pharma.

Medicare beneficiaries will benefit by price reductions for drugs intended for patients with common diseases, such as diabetes, heart failure, psoriasis, ulcerative colitis, blood clotting disorders, and blood cancers

The discounts are considerable ranging from 79%% to 36%

Here’s the list:

Januvia: Manufactured by Merck Sharp Dohme to treat diabetes, the negotiated price is $113 for a 30-day supply, which is a 79% reduction 

 Fiasp  (insulin} FlexTouch; Fiasp PenFill; NovoLog; NovoLog FlexPen; NovoLog PenFill: Manufactured by Novo Nordisk to treat diabetes, the negotiated price is $119 for a 30- day supply, which is a 76% reduction. 

Farxiga: Manufactured by AstraZeneca AB to treat diabetes, heart failure and chronic kidney disease, the negotiated price is $178.50 for a 30-day supply, a reduction of 68%. 

Enbrel: Manufactured by Immunex Corp. to treat rheumatoid arthritis, psoriasis and psoriatic arthritis, the negotiated price is $2,355 for a 30-day supply, which is a 67% cut. 

Jardiance: Manufactured by Boehringer Ingelheim to treat diabetes, heart failure and chronic kidney disease, the negotiated price is $197 for a 30-day supply, which is a 66% savings. 

Stelara: Manufactured by Janssen Biotech Inc. to treat Psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis, the negotiated price is $4,695 for a 30-day supply, which is a 66% reduction. 

Xarelto: Manufactured by Janssen Pharms for prevention and treatment of blood clots, and reduction of risk for patients with coronary or peripheral artery disease, the negotiated price is $197 for a 30-day supply. It’s a 62% reduction 

Eliquis: Manufactured by Bristol Myers Squibb for prevention and treatment of blood clots, the negotiated price is $231 for a 30-day supply, reduction of 56% 

Entresto: Manufactured by Novartis Pharms Corp to treat heart failure, the negotiated price is $295 for a 30-day supply, which is a 53% reduction. 

Imbruvica: Manufactured by Pharmacyclics LLC to treat blood cancers, the negotiated price is $9,319 for a 30-day supply, which is a 38% cut. 

These drugs are heavily marketed by the media on television and cable television.

Patient awareness causes them to ask for these drugs from physicians. The fact that there have been significant reductions in prices will increase patient demand.

Whatever price reductions the increase in demand will offset the reduction in price.

Thursday, August 15, 2024

Private Equity Ownership of Medical Practice and Hospital Ownership and What it does to the Health Care System

Why private equity is bad for your health.


Key Points

  • During the first half of 2024, nine private equity-owned healthcare companies have filed for bankruptcy, comprising 23% of all large US healthcare bankruptcies so far this year.
  • Some other private equity-owned healthcare companies have also defaulted on their debt but avoided bankruptcy court through distressed debt exchanges. At least six major healthcare companies have completed distressed exchanges this year.
  • Many more private equity-owned healthcare companies are highly leveraged and considered at high risk for bankruptcy, including multiple companies that have taken on debt to finance payouts to their private equity owners.

Private equity firms, which characteristically use excessive debt and aggressive financial strategies, are key drivers in a recent wave of healthcare bankruptcies in the US, threatening the stability of essential healthcare services across the country.

In our April report, PESP found that at least 17 (21%) of the 80 large healthcare companies that filed for bankruptcy last year were owned by private equity firms.

This trend has continue in 2024. In the first six months of this year, PESP has tracked at least nine bankruptcies by companies that were private equity-owned, which accounts for 23% of all healthcare bankruptcies filed this year.

On top of that, there have been at least six more defaults by PE-owned healthcare companies (where the companies managed to restructure their debt outside of bankruptcy court).

The rise in healthcare bankruptcies, and bankruptcies by private equity-owned healthcare companies in particular, stems from a few factors. Private equity firms routinely use much higher levels of debt than other companies, often the result of leveraged buyouts and aggressive debt-funded growth strategies.

Private equity owns or recently owned companies that accounted for three of the four largest healthcare bankruptcies of the year so far, where the companies’ total liabilities exceeded $1 billion: Consulate Health Care, Steward Health Care, and Cano Health.[13]

Not included in that list is Careismatic Brands, a medical scrubs manufacturer owned by Partners Group that also had a >$1 billion bankruptcy,[14] but is classified within the consumer discretionary market rather than healthcare.[15]

Some private equity firms even add additional debt to their portfolio companies to fund shareholder payouts, known as “dividend recapitalizations.” Just last month, private equity-owned medical debt collector Ensemble RCM took out an over $800 million loan to finance a payout to its private equity owners.[1]

Private equity’s aggressive use of debt leaves companies more vulnerable to changing market conditions, including high interest rates and rising labor costs.

Private Equity Bankruptcy Trend Has Continued in 2024

Of the 40 large healthcare companies that have filed for bankruptcy so far this year (January-June 2024), nine companies are or were recently backed by private equity, accounting for 23% of the total filings.[2]

Most of the bankruptcies are filed as Chapter 11, which allows for a financial reorganization over time to allow the PE to survive.  However many PEs in Chapter 11 proceed to Chapter 7 (a complete liquidation of all assets) In any case the entity is in the hands of a trustee who will make decisions on the PE's ability to meet the Chapter 11 bankruptcy or proceed to a Chapter 7 liquidation

To make matters worse PEs often borrow to pay shareholder dividends, to eliminate shareholder exits.

Any entity considering relief from a private entity should evaluate the buyer, its track record, financial statements, and history of previous acquisitions.

The makeup of PEs varies, from larger Venture Capital investors to smaller non-financial firms.  Firms may include individual hospitals, clinics, or smaller groups of interested competitors.. This group may include competitors who want to increase their market share to improve their value to insurers by expanding their coverage area.

Physician Involvement

Neophyte physicians should examine the financial health of their proposed employer.  They must avoid distressed entities such as group practices clinics and hospitals. Should the entity file for Chapter 7 many physicians could face loss of income and a forced move. Non-partners face the risk of termination, while partners may face liabilities for Chapter 7.  This is good. reason for having a personal Chapter S to shield themselves from personal liability.


Private equity healthcare bankruptcies show no signs of slowing

Tuesday, August 13, 2024

Which strains of tuberculosis are the most in | EurekAlert!


At a glance:

  • Highly localized TB strains are less infectious in cosmopolitan cities and more likely to infect people from the geographic area that is the strain’s natural habitat.

  • The findings offer new clues for tailoring preventive treatments after exposure to TB based on strain-host affinity.

  • The research provides the first controlled evidence that TB strains may evolve with their human hosts, adapting to be more infectious to specific populations.


For some forms of tuberculosis, the chances that an exposed person will get infected depend on whether the individual and the bacteria share a hometown, according to a new study comparing how different strains move through mixed populations in cosmopolitan cities.

Results of the research, led by Harvard Medical School scientists and published Aug. 1 in Nature Microbiologyprovide the first hard evidence of long-standing observations that have led scientists to suspect that pathogen, place, and human host collide in a distinctive interplay that influences infection risk and fuels differences in susceptibility to infection.

The findings may also help inform new prevention and treatment approaches for tuberculosis, a wily pathogen that, each year, sickens more than 10 million people and causes more than a million deaths worldwide, according to the World Health Organization.

Where widespread Haarlem strains are prevalent

In these nations, at least 10 percent of the strains in a multinational database of tuberculosis genotypes were from the globally distributed Haarlem sublineage of Lineage 4, a group of TB varieties known as the Euro-American lineage that is prevalent around the world.

The widespread Haarlem sublineage of tuberculosis is prevalent in nations around the world, including countries in the Americas, Africa, Asia, and Europe.


 In the current analysis, believed to be the first controlled comparison of TB strains’ infectivity in populations of mixed geographic origins, the researchers custom-built a study cohort by combining case files from patients with TB in New York City, Amsterdam, and Hamburg. Doing so gave them enough data to power their models.

The analysis showed that close household contacts of people diagnosed with a strain of TB from a geographically restricted lineage had a 14 percent lower rate of infection and a 45 percent lower rate of developing active TB disease compared with those exposed to a strain belonging to a widespread lineage.

The study also showed that strains with narrow geographic ranges are much more likely to infect people with roots in the bacteria’s native geographic region than people from outside the region.

The researchers found that the odds of infection dropped by 38 percent when a contact is exposed to a restricted pathogen from a geographic region that doesn’t match the person’s background, compared with when a person is exposed to a geographically restricted microbe from a region that does match their home country. This was true for people who had lived in the region themselves and for people whose two parents could each trace their heritage to the region.

This pathogen-host affinity points to a shared evolution between humans and microbes with certain biological features rendering both more compatible and fueling the risk for infection, the researchers said.

“The size of the effect is surprisingly large,” said Maha Farhat, the Gilbert S. Omenn, MD ’65, PhD Associate Professor of Biomedical Informatics in the Blavatnik Institute at HMS. “That’s a good indicator that the impact on public health is substantial.”

Why differences matter

Thanks to the growing use of genetic sequencing, researchers have observed not all circulating strains are created equal. Some lineages are widespread and responsible for much of the TB around the world, while others are prevalent only in a few restricted areas. Given that the complex nature of TB transmission in high-incidence settings where people often have multiple exposures to different lineages, researchers have not been able to compare strains under similar conditions and have been left to speculate about possible explanations for the differences between strains.

Many factors increase the risk of contracting tuberculosis from a close contact. One of the best predictors of whether a person will infect their close contacts is bacterial load, measured by a test called sputum smear microscopy, which shows how many bacteria a person carries in their respiratory system.

However the new study showed that for geographically restricted strains, whether a person has ancestors who lived where the strain is common was an even bigger predictor of infection risk than bacterial load in the sputum. In the cases analyzed in the study, this risk of common ancestry even outweighed the risk stemming from having diabetes and other chronic diseases previously shown to render people more susceptible to infection.

The findings add to a growing body of evidence of the importance of paying attention to the wide variation between different lineages of tuberculosis and to the details of how different lineages of tuberculosis interact with different host populations.

Previous studies have shown that some genetic groups of TB are more prone to developing drug resistance and that TB vaccines appear to work better in some places than others. There is also evidence that some treatment regimens might be better suited to some strains of TB than others.

“These findings emphasize how important it is to understand what makes different strains of TB behave so differently from one another, and why some strains have such a close affinity for specific, related groups of people,” said Matthias Groeschel, research fellow in biomedical informatics in Farhat’s lab at HMS; resident physician at Charité, a university hospital in Berlin; and the study’s first author.

In addition to the analysis of clinical, genomic, and public health data, the researchers also tested the ability of different strains of TB to infect human macrophages, a type of immune cell that TB hijacks to cause infection and disease. The researchers grew cells from donors from different regions. Once again, cell lines from people with ancestry that matched the native habitat of a restricted strain of tuberculosis bacteria were more susceptible to the germs than cells from people from outside the area, mirroring the results of their epidemiologic study.

Until now, most experiments of the interaction between human immune cells and TB have not compared how TB interacts with cells of hosts from different populations or places, the researchers said.

While this experiment was not designed to capture insights about the mechanism underlying the affinity between human and TB populations sharing geographic backgrounds, it highlights the importance of using multiple strains of TB and cells from diverse populations to inform treatment and prevention. It also points to the need for more basic research to understand the genomic and structural differences in how bacterial and host cells interface, the researchers said.



Which strains of tuberculosis are the most in | EurekAlert!

Monday, August 12, 2024

Health Care is in a death spiral

 Death Spiral

1. Doctor Shortage, early retirement, or change to a nonclinical career. Boomer bulge. Incoming new doctors often get MBAs and go to non-clinical careers in IT,  or AI.

2. Nurse shortage.  Early dropout.

3. Hospital bed shortage

4. Continuing inflation at 8% / year

Monday, August 5, 2024

The Early Preveniton of Alzheimer's Diseae

As the population ages and physical health allows activities later in life, it becomes more important to recognize the early onset of dementia and/or Alzheimer's Disease

The future below outlines some early signs and symptoms of Alzheimer's Disease.

1. New research suggests that Alzheimer's disease may be reversible through lifestyle changes, including:

   - Adopting a plant-based diet

   - Engaging in regular exercise, including strength training

   - Practicing meditation or yoga

   - Increasing social engagement

2. The research study followed 51 adults in their 70s with mild cognitive impairment or early Alzheimer's. The group that made the lifestyle changes showed significant improvements, with 70% either stabilizing or markedly improving their cognitive function.

3. Examples of improvements seen in the study participants include:

   - Resumed ability to read, play music, manage affairs, and follow complex movie plots

   - Reversal of symptoms in a participant named Cici Zerbe, who made lifestyle changes after the study ended

4. Experts like Dr. Dean Ornish and Dr. Richard Isaacson recommend the following for brain health and Alzheimer's prevention:

   - Eating a mostly plant-based diet

   - Exercising regularly, including brisk walking with a weighted belt

   - Managing blood sugar levels

   - Maintaining mental stimulation and social engagement

5. The article highlights the personal experiences of Dr. Ornish and Dr. Gupta, who have had family members affected by Alzheimer's, and their motivation to explore lifestyle-based approaches to prevention and treatment.

In summary, the research suggests that Alzheimer's disease may be reversible through a combination of dietary, exercise, and lifestyle changes, providing hope for those affected by the disease.

'If Walmart can't do it … how can the average physician survive?': Independent practices becoming less feasible

Do you wonder why it takes so long to see a physician?  Besides to being required an enormous volume of patients, and being limited to ten-minute visits among the paucity of general physicians, there are an overwhelming number of financial constraints.


Independent physician practices are getting hit the hardest – only 44% of physicians owned their practice as of 2022, according to an American Medical Association report, compared with 76% in the early 1980s.

New data from consulting firm Avalere in a study sponsored by the Physicians Advocacy Institute estimated roughly 8,100 private practices were acquired by hospitals or corporations in 2022 and 2023, and 19,100 physicians became employees of hospitals or other corporate entities, up 5.1% since 2022. 

Physicians aren't the only ones struggling to meet margins in healthcare. Walmart announced plans to shutter all 51 health center locations and discontinue its virtual-care services in April. According to The Wall Street Journal, the company was unable to establish a sustainable business model despite positive patient feedback. 

CVS Health, who recently spent $11.5 billion acquiring Oak Street Health, is also facing headwinds. CVS was aiming to emulate the success of UnitedHealth Group, which owns Optum, the country's largest employer of physicians. But, according to the Journal, earnings have disappointed investors. 

"When companies like Walmart and CVS, known for delivering products at a cost-effective price, look at healthcare, jump in and then jump out saying it's unsustainable, it raises concerns," Nari Heshmati, MD, chief physician executive of Fort Myers, Fla.-based Lee Health's Physician Group , told Becker's. "If Walmart can't do it with embedded clinics in their stores, how can the average physician practice survive?"

This will only get more difficult as the behemoths in healthcare exert greater pressure on physician pay, as evidenced by continued reimbursement reductions by CMS. On July 10, CMS proposed a 2.8% conversion factor reduction to its physician fee schedule. According to research from the American Medical Association, Medicare physician payment declined 29% from 2001 to 2024 without accounting for the most recent proposed cut. 

The bottom line is getting bigger is not the ultimate answer except for capturing a greater area for acceptance by huge payors such as Humana, United Health Group, Aetna, and others.

"The proposed CMS pay cut for physicians can have significant implications across the healthcare system," Ernest Braxton, MD, spine and neurological surgery specialist at Vail-Summit Orthopaedics and Neurosurgery, told Becker's. "CMS efforts to control costs will have unintended consequences on physician workforce morale, patient care quality, and healthcare access. This will be the last straw for many private practice physicians. We will see more early retirements and a large number of physicians opting out of Medicare in order to create private pay contracts with patients for non-urgent/emergency care — shifting the economic burden to healthcare consumers."

Many feel the pressure to remain financially feasible weighs on healthcare success. 







'If Walmart can't do it … how can the average physician survive?': Independent practices becoming less feasible